What Survives When Ketanserin Blocks a Psilocybin Trip
Content warning: discusses psychedelic drug pharmacology
A pharmacology deep dive into which effects of psilocybin persist under 5-HT2A blockade, moving from mechanism to the actual human trial data.
Related
Mapping Ibrutinib's Gene Interactions and Resistance Variants
A biomedical database walkthrough tracing which genes interact with the leukemia drug Ibrutinib, and which of their variants predict resistance or response.
A 2024-2025 tour of migraine drug research
A digest of 2024-2025 migraine drug research spanning CGRP therapies, a dual-target compound, nerve blocks, gut microbiota links, and placebo response rates.
Adderall's Molecular Path Through the Prefrontal Cortex
A rapid dive into how amphetamines shift dopamine signaling, heart-rate variability, and cortical gain control, pushing past what neuroscience can resolve.
PM20D1 Reveals How Ancient Peptidases Evolve New Functions
A research explainer on how the enzyme PM20D1 evolved from an ancestral peptidase into a lipid-signaling enzyme that regulates thermogenesis in mammals.